目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing this Study
What’s New in this Report
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for Renal Biomarkers, by Segment, Through 2027
Figure Summary : Global Market for Renal Biomarkers, by Type, 2019-2027

Chapter- 3: Market Overview
Introduction
Market Dynamics
Regulatory Process for Biomarkers

Chapter- 4: Impact of COVID-19 Pandemic
Impact of COVID-19 on Renal Biomarker Market
Chronic Dialysis Patients

Chapter- 5: Global Renal Biomarker Market by Type
Overview
Filtered Renal Biomarkers (Impaired Tubular Reabsorption)
Upregulated Biomarkers
Preformed
Other Biomarkers

Chapter- 6: Global Market for Renal Biomarkers by Region
North America
Europe
Asia-Pacific
Rest of the World
Table 9 : Global Market for Renal Biomarkers, by Region, Through 2027
Table 10 : AKI in Developed and Developing Countries

Chapter- 7: Renal Biomarker Market by End User
Hospitals
Research Centers
Other End Users
Table 31 : Global Market for Renal Biomarkers, by End User, Through 2027

Chapter- 8: Renal Biomarker Market by Technique
Overview
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassays
Colorimetric Assays
Chemiluminescent Enzyme Immunoassays
Other Detection Methods

Chapter- 9: Competitive Landscape
Figure 11 : Shares of Leading Companies in the Renal Biomarker Market
Table 34 : Company Developments, 2019-2022

Chapter- 10: Company Profiles
ABBOTT LABORATORIES
BECKMAN COULTER INC.
BIOMERIEUX
BIOPORTO A/S
BIO-RAD
ENZO BIOCHEM INC.
GENTIAN DIAGNOSTIC AB
HYTEST LTD.
NEPHROSANT
Nexelis
PROTEOMICS INTERNATIONAL LABORATORIES LTD.
RANDOX LABORATORIES LTD.
ROCHE (F. HOFFMANN-LA ROCHE AG)
SPHINGOTEC
THERMO FISHER SCIENTIFIC

Chapter- 11: Patent Review
Table 63 : Precision Medicine Patent Criteria in U.S. and Europe
Table 64 : List of Renal Biomarker Patents

Chapter- 12: Clinical Trial Analysis
Figure 12 : Clinical Trials of Renal Biomarkers, by Therapeutic Area, 2019 to October 2022
Figure 13 : Clinical Trials of Renal Biomarkers, by Sponsor
Figure 14 : Clinical Trials of Renal Biomarkers, by Location